Anticoagulants for PFO Patients

CompletedOBSERVATIONAL
Enrollment

277

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Patent Foramen Ovale
Interventions
PROCEDURE

PFO closure

PFO closure

DRUG

anticoagulant

rivaroxaban

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER

NCT06375070 - Anticoagulants for PFO Patients | Biotech Hunter | Biotech Hunter